Clinical Trial Update: Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the concomitant use of tramadol with duloxetine or pregabalin has been withdrawn. The study involved patients with diabetic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Postherpetic Neuralgia

Drugs mentioned

• Duloxetine (DULOXETINE)
• Pregabalin (Pregabalin)
• Tramadol (tramadol)

Snippet

Sponsor: Turku University Hospital | Conditions: Diabetic Polyneuropathy, Postherpetic Neuralgia | Phase 4 | Status: WITHDRAWN